These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2143107)

  • 1. Comparative studies on the antitumor and immunosuppressive effects of the new fluorouracil derivative N4-trimethoxybenzoyl-5'-deoxy-5-fluorocytidine and its parent drug 5'-deoxy-5-fluorouridine.
    Miwa M; Ishikawa T; Eda H; Ryu M; Fujimoto K; Ninomiya Y; Umeda I; Yokose K; Ishitsuka H
    Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):998-1003. PubMed ID: 2143107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative antitumor activity and intestinal toxicity of 5'-deoxy-5-fluorouridine and its prodrug trimethoxybenzoyl-5'-deoxy-5-fluorocytidine.
    Ninomiya Y; Miwa M; Eda H; Sahara H; Fujimoto K; Ishida M; Umeda I; Yokose K; Ishitsuka H
    Jpn J Cancer Res; 1990 Feb; 81(2):188-95. PubMed ID: 2139643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activities of a novel fluoropyrimidine, N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine (capecitabine).
    Ishikawa T; Fukase Y; Yamamoto T; Sekiguchi F; Ishitsuka H
    Biol Pharm Bull; 1998 Jul; 21(7):713-7. PubMed ID: 9703255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and interaction with uridine phosphorylase of 5'-deoxy-4',5-difluorouridine, a new prodrug of 5-fluorouracil.
    Ajmera S; Bapat AR; Stephanian E; Danenberg PV
    J Med Chem; 1988 Jun; 31(6):1094-8. PubMed ID: 2967375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunotoxicity assessment of N4-Trimethoxybenzoyl-5'-deoxy-5- fluorocytidine (Ro 09-1390) and 5'-deoxy-5-fluorouridine (5'-DFUR) in BDF1 mice.
    Inoue T; Anderson TD; Hayes TJ; Horii I
    J Toxicol Sci; 1996 Feb; 21(1):29-39. PubMed ID: 8852286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.
    Endo M; Shinbori N; Fukase Y; Sawada N; Ishikawa T; Ishitsuka H; Tanaka Y
    Int J Cancer; 1999 Sep; 83(1):127-34. PubMed ID: 10449619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine.
    Armstrong RD; Diasio RB
    Cancer Res; 1980 Sep; 40(9):3333-8. PubMed ID: 6253060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of antitumor activity of 5'-deoxy-5-fluorouridine by thymosin fraction 5 in mouse bladder cancer cells in vitro and in vivo.
    Ikemoto S; Sugimura K; Wada S; Yasumoto R; Yamamoto K; Kishimoto T
    Cancer Lett; 1999 Oct; 145(1-2):121-6. PubMed ID: 10530779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.
    Ishikawa T; Sekiguchi F; Fukase Y; Sawada N; Ishitsuka H
    Cancer Res; 1998 Feb; 58(4):685-90. PubMed ID: 9485021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts.
    Ishikawa T; Utoh M; Sawada N; Nishida M; Fukase Y; Sekiguchi F; Ishitsuka H
    Biochem Pharmacol; 1998 Apr; 55(7):1091-7. PubMed ID: 9605432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the antitumor activities of 5'-deoxy-5-fluorouridine and its prodrug trimethoxybenzoyl-5'-deoxy-5-fluorocytidine (Ro09-1390) on human digestive organ cancer xenograft lines transplanted into nude mice.
    Nio Y; Kimura H; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Araya S; Meyer C; Fukumoto M
    Anticancer Drugs; 1992 Aug; 3(4):387-93. PubMed ID: 1421435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine.
    Shimma N; Umeda I; Arasaki M; Murasaki C; Masubuchi K; Kohchi Y; Miwa M; Ura M; Sawada N; Tahara H; Kuruma I; Horii I; Ishitsuka H
    Bioorg Med Chem; 2000 Jul; 8(7):1697-706. PubMed ID: 10976516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.
    Miwa M; Ura M; Nishida M; Sawada N; Ishikawa T; Mori K; Shimma N; Umeda I; Ishitsuka H
    Eur J Cancer; 1998 Jul; 34(8):1274-81. PubMed ID: 9849491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schedule dependency of antitumor activity in combination therapy with capecitabine/5'-deoxy-5-fluorouridine and docetaxel in breast cancer models.
    Fujimoto-Ouchi K; Tanaka Y; Tominaga T
    Clin Cancer Res; 2001 Apr; 7(4):1079-86. PubMed ID: 11309360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of cytotoxic activity of 5'-deoxy-5-fluorouridine.
    Armstrong RD; Connolly KM; Kaplan AM; Cadman E
    Cancer Chemother Pharmacol; 1983; 11(2):102-5. PubMed ID: 6226452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of administration route in the therapeutic efficacy of doxifluridine.
    Trave F; Canobbio L; Au JL; Rustum YM
    J Natl Cancer Inst; 1987 Mar; 78(3):527-32. PubMed ID: 2950266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alpha and 5'-deoxy-5-fluorouridine in colon cancer: effects as single agents and in combination on growth of xenograft tumours.
    Laurent PL; Tevaearai HT; Eliason JF; Givel JC; Odartchenko N
    Eur J Cancer; 1994; 30A(12):1859-65. PubMed ID: 7880618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridine.
    Eda H; Fujimoto K; Watanabe S; Ishikawa T; Ohiwa T; Tatsuno K; Tanaka Y; Ishitsuka H
    Jpn J Cancer Res; 1993 Mar; 84(3):341-7. PubMed ID: 8486533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Discovery and development of novel anticancer drug capecitabine].
    Ishitsuka H; Shimma N; Horii I
    Yakugaku Zasshi; 1999 Dec; 119(12):881-97. PubMed ID: 10630095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
    Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
    Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.